Top compounds associated with response to EIF2S2


Feature Type Standardized
Nominal ANOVA
mRNA barasertib CTRPv2 pan-cancer AAC -0.15 4e-06
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 4e-06
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.15 8e-06
mRNA AC55649 CTRPv2 pan-cancer AAC -0.17 9e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.13 2e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA neratinib CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.15 3e-05
Download CSV